Ignite Creation Date:
2025-12-24 @ 2:54 PM
Ignite Modification Date:
2026-02-28 @ 5:52 PM
Study NCT ID:
NCT03777059
Status:
COMPLETED
Last Update Posted:
2021-07-09
First Post:
2018-12-13
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
12-Week Placebo-controlled Study of Atogepant for the Preventive Treatment of Migraine in Participants With Episodic Migraine
Sponsor:
Allergan
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
3101-301-002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None